Compare AZI & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AZI | AIDX |
|---|---|---|
| Founded | 2010 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Precision Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7M | 4.9M |
| IPO Year | 2023 | 2025 |
| Metric | AZI | AIDX |
|---|---|---|
| Price | $1.12 | $0.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 46.2K | ★ 46.7K |
| Earning Date | 05-29-2026 | 11-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.48 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,045,133.00 |
| Revenue This Year | N/A | $44.20 |
| Revenue Next Year | N/A | $95.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.71 |
| 52 Week Low | $0.03 | $0.33 |
| 52 Week High | $7.00 | $14.09 |
| Indicator | AZI | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 38.91 | 36.31 |
| Support Level | $1.01 | N/A |
| Resistance Level | $1.33 | $0.49 |
| Average True Range (ATR) | 0.05 | 0.05 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 15.46 | 27.33 |
Autozi Internet Technology (Global) Ltd provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels in China. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, it has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the auto parts & auto accessories sales.
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.